retatrutide trial update october 2025 Lilly's triple agonist delivers up to 71.2 lbs of weight loss TRIUMPH-1 Trial Results: Retatrutide for

Most researchers report no noticeable potency issues at the 5-week mark, but conservative protocols suggest using the vial within 4 weeks and discarding any remainder

This Retatrutide vs Mounjaro comparison will explore how these treatments stack up from how they work, to the results theyre getting, to when you can access them

Clinical trials such as the STEP program (semaglutide) and SURMOUNT trials (tirzepatide) have demonstrated improvements in physical functioning and quality of life scores, which patients often interpret as increased energy

In October 2024, the FDA removed tirzepatide from the drug shortage list, which technically ended the legal basis under which most compounding pharmacies were producing it

M., Astrup, A., & Hjorth, M